Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.43 +0.04 (+1.88%)
As of: Oct 21, 2026 · 11:41 AM EDT

Zentalis Pharmaceuticals (ZNTL) Operating Margin (2024)

Updated

Zentalis Pharmaceuticals' Operating Margin came in at -185.55% for Q4 2024.

Analysis

Zentalis Pharmaceuticals (ZNTL) Operating Margin (2024) Analysis & Trends

For FY2024, Zentalis Pharmaceuticals' Operating Margin was -283.57%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 Zentalis Pharmaceuticals 173.32 Mn -737.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -185.55%
Mar 31, 2024 -61.06%
API Access

Zentalis Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ZNTL&period=max&api_key=YOUR_API_KEY